HOME >> MEDICINE >> NEWS
Nanomolecular 'smart bombs' seek and destroy cancer cells

ANN ARBOR---University of Michigan scientists will receive $4.4 million from the National Cancer Institute to develop an innovative approach to cancer treatment---nanomolecular "smart bombs" that sense pre-malignant and cancerous changes inside living cells and then destroy the cells before they can grow into tumors.

"Our goal is to create a multi-functional therapeutic device small enough to work inside living cells," says James R. Baker Jr., M.D., the project's principal investigator who directs the Center for Biologic Nanotechnology in the U-M Medical School. "The device will target to abnormal cells. If it confirms pre-cancerous lesions, it can release a substance to kill the cell and then verify that the cell is dead."

The U-M project is one of five funded by the NCI's new Unconventional Innovations Program, which supports peer-reviewed, high-risk, high-impact research with the potential to revolutionize cancer care.

"During the last decade, scientists have learned a great deal about biochemical and genetic changes within cells that can lead to cancer," says Allen Lichter, M.D., a cancer specialist and dean of the U-M Medical School. "Now we need to develop new ways to identify and treat these changes at the molecular level long before they can be detected with current technology. Research funded by this National Cancer Institute program could help bring us closer to that goal."

Synthetic polymers called dendrimers will be used as delivery vehicles to transport anti-cancer drugs and sensing agents into cells, according to Baker. "Dendrimers already are used in many biological applications," he says. "They have been shown to readily enter cells, and they have little toxicity when given intravenously."

Fifteen researchers from the U-M Medical School, the U-M College of Engineering and the U-M College of Literature, Science, and the Arts will collaborate on the three-year research project. Working together, these scientists hope to d
'"/>

Contact: Sally Pobojewski
pobo@umich.edu
734-647-1844
University of Michigan
18-Oct-1999


Page: 1 2

Related medicine news :

1. Canadian researchers to develop smart drug to repair psychiatric disorders
2. Using smart fluids to retrain muscles
3. UF smart home demonstrates concept of automated elderly help and care
4. Researchers create lung cancer cluster bombs
5. Obesity reversed in mice by destroying blood vessels that service fat cells
6. UCLA scientists invent search-and-destroy method to flush HIV out of hiding places in body
7. The trojan clot-buster: Drug-coated red blood cells destroy blood clots from within
8. Molecular nanogenerator developed that can target cancer cells and destroy them
9. Hormonal treatment improves survival in high-risk prostate cancer patients
10. International breast cancer prevention study launches in the United States and Canada
11. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nanomolecular smart bombs seek and destroy cancer cells

(Date:5/23/2013)... Clinic researchers have used next generation genomic analysis to ... tumors have similar genetic origins, which may help in ... the journal Cancer Research . , "This is ... generation sequencing in adjacent Gleason patterns in the same ... pathology," says ,John Cheville, M.D., Mayo Clinic pathologist and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Dr. Katherine ... new charitable organization in Orange County, OCCares , will ... Orange County. The event details are as follows: , ... Academy Auditorium, 13732 Clinton Street, Garden Grove, CA 92843 , ... crossover music by Christian vocalists Charmaine & Jonathan Thulin. ...
(Date:5/23/2013)... New York, NY (PRWEB) May 23, 2013 ... http://bit.ly/Z4m6UI , Canadian tech start-ups are increasingly seeing ... deals with larger US-based companies, according to ... business development engine. , The company has compiled ... entitled Borderless Investments. The findings of the research have ...
(Date:5/23/2013)... 23, 2013 Cheap Concert Tickets announces that ... of 2013 at stadiums throughout North America. This well ... Paul McCartney concert tickets to help McCartney fans see Sir ... Concert Tickets, states that she is also offering the customer ... Being a baby boomer, she is also a huge ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Symptoms of ... psychiatric disorders, complicating diagnosis and treatment. But researchers ... that may be unique to borderline personality disorder: ... face. , , "They have difficulty processing facial ... a neutral face," said Anthony Ruocco, a clinical ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3
(Date:5/23/2013)...  Echo Pharma Acquisition Limited ("Royalty Pharma") announced today ... Threshold from 90 percent to 50 percent of Maximum ... with the terms of the Revised Offer Document issued ... Under the terms of the Increased Offer, Royalty Pharma ... ) for $12.50 per share in cash. The Increased ...
(Date:5/23/2013)... 23, 2013   BioLife Solutions , Inc. (OTC:BLFS), ... grade hypothermic storage and cryopreservation freeze ... aseptic media manufacturer , today announced its participation at ... Congress 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President ...
(Date:5/23/2013)... PARIS , May 23, 2013 /PRNewswire/ ... developer and manufacturer of precision guided therapy tools designed ... peripheral vascular disease, today announced preliminary results from the ... ndependent S tenosis E valuation) II trial ... at EuroPCR 2013. These prospective results confirm prior retrospective ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5
Cached News: